Retatrutide × NextGen Peptides - Lab Test, February 2026
Test results
About this test
Retatrutide 10mg from NextGen Peptides achieves 99.413% purity according to this independent HPLC analysis conducted by Janoshik Labs on February 5, 2026. The tested quantity was 10.92mg, exceeding the stated label amount of 10mg.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for metabolic regulation, weight management, and glycemic control. A purity level of 99.413% demonstrates pharmaceutical-grade synthesis with minimal contamination and high product consistency.
The certificate of analysis (Task #105652) is available for verification at www.janoshik.com/verify/ with the unique key GPTYKRYINCEQ9. The test includes assessment of the peptide vial or vials.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.